rss
Thorax 2004;59:453-455 doi:10.1136/thx.2004.026641
  • Editorial

Monitoring mast cell activation by prostaglandin D2 in vivo

  1. S-E Dahlén,
  2. M Kumlin
  1. Experimental Asthma and Allergy Research, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
  1. Correspondence to:
    Professor S-E Dahlén
    Experimental Asthma and Allergy Research, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm SE-171 77, Sweden; se.dahlenimm.ki.se

    Prostaglandin D2 is a useful in vivo marker of mast cell activation in humans

    While the pro-inflammatory role of eosinophilic granulocytes in asthma is currently under debate, an increasing body of evidence suggests that mast cells may indeed orchestrate many of the characteristic pathophysiological changes in asthma.1 There are also indications that the mast cell may be an effector cell in other lung diseases such as chronic obstructive pulmonary disease2–4 and lung fibrosis.5 Given the location of mast cells at multiple sites within the airways,1 they clearly have the potential to function as sensors of alterations in the microenvironment—be it to inhaled or bloodborne substances, microbes, or other insults that require a prompt host defence reaction. Their versatility is demonstrated by the great number of stimuli that trigger mast cell activation (fig 1). In addition to classical IgE dependent degranulation of mast cells, transduction pathways resulting in mast cell activation may be triggered by, for example, adenosine,6 hyperosmolarity,7 and lipopolysaccharide.8

    Figure 1

    Mast cells may produce a large number of mediators, enzymes, cytokines and other factors in response to allergic (IgE dependent) or non-allergic activation (adenosine, exercise, endotoxin, mannitol, non-steroidal anti-inflammatory drugs (NSAIDs) in NSAID intolerant subjects, etc). However, only tryptase and prostaglandin (PG) D2 (boxed) are specific markers of mast cell activation. As reported by Bochenek et al in this issue, measurement of PGD2 and its metabolites is currently the most sensitive strategy to monitor mast cell activation in human subjects. LTC4 = leukotriene C4.

    MAST CELL MARKERS

    Although many mast cell mediators or products serve as useful markers of mast cell activation in vitro, it has been notoriously difficult conclusively to establish mast cell activation in human studies. For example, it is difficult to catch the short lived increase in …

    This Article

    Services

    1. Request permissions

    Social bookmarking

    Register for free content


    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
    View free sample issue >>

    Free archive
    The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.